Legend Biotech
LEGN
LEGN
207 hedge funds and large institutions have $3.23B invested in Legend Biotech in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 93 increasing their positions, 52 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 205 → 207 (+2)
27% less capital invested
Capital invested by funds: $4.44B → $3.23B (-$1.21B)
43% less call options, than puts
Call options by funds: $8.76M | Put options by funds: $15.3M
Holders
207
Holding in Top 10
8
Calls
$8.76M
Puts
$15.3M
Top Buyers
| 1 | +$114M | |
| 2 | +$66.2M | |
| 3 | +$51.7M | |
| 4 |
DM
Deerfield Management
New York
|
+$50.5M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$46.7M |
Top Sellers
| 1 | -$159M | |
| 2 | -$142M | |
| 3 | -$37.6M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$21.2M |
| 5 |
CCM
Cutter Capital Management
New York
|
-$15.9M |